| abstract |
Embodiments described in the specification include methods and formulations for treating influenza, cold and related acute inflammation. The methods and formulations include, but are not limited to, methods and formulations for delivering levocetirizine and montelukast at concentrations effective for the patient in need. The methods and formulations may comprise conventional and / or modified-release elements to enable drug delivery to the patient. |